Deutsche Intensivpflege Holding B.V. (DIH) has acquired Linde Remeo Deutschland GmbH as part of a structured bidding process. Completion of the transaction is still subject to approval by the German Federal Cartel Office. <\/p>\n\n
Remeo is part of the Linde Group’s Healthcare division and offers medium and long-term care for respiratory patients with sub-acute and chronic illnesses. With an innovative concept for long-term ventilated patients, Remeo closes the gap between intensive care treatment and the return to the home environment. Remeo is active in Germany with around 200 employees at seven locations. <\/p>\n\n
Founded in 2013, DIH is one of the largest non-hospital intensive care groups in Germany and currently cares for around 550 patients in need of intensive care nationwide. With more than 2,500 employees, DIH provides care for adults and children both individually and in over 60 shared apartments. In recent years, the company has acquired particular expertise in the field of intensive care for children. <\/p>\n\n
In November 2016, Renzenbrink & Partner advised Ergon Capital Partners on the acquisition of a majority stake in DIH. Subsequently, DIH acquired numerous outpatient care service providers throughout Germany as part of its growth strategy and was advised by Renzenbrink & Partner on all legal aspects (including integration measures) of all transactions. <\/p>\n\n
The Renzenbrink & Partner team for the acquisition of Linde Remeo Deutschland consisted of partners Dr. Dennis Schlottmann<\/a> (lead), Dr. Ulf Renzenbrink<\/a> (both Corporate\/M&A) and Marc H. Kotyrba<\/a> (Tax) as well as associate Dr. Alexander Haunschild<\/a> (Corporate\/M&A).<\/p>\n","protected":false},"featured_media":987,"template":"","class_list":["post-1552","deals","type-deals","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n